Chen, Ying
First Affiliated Hospital of Xi'an Jiaotong University · First Hospital of Xi'an · Xi'an Jiaotong University
4 papers on CoChatORCID 0009-0005-8351-6620
Most cited papers
- Verified
The NLRP3 inflammasome: contributions to inflammation-related diseases
Chen, Y., Ye, X., Escames, G., Lei, W., Zhang, X., Li, M., Jing, T., Yao, Y., Qiu, Z., Wang, Z., et al. (2023) · Cellular & Molecular Biology Letters
Inflammasome and immune disordersImmune Response and Inflammation
Cited by 492
- Verified
Phase i study of single-agent utomilumab (PF-05082566), a 4-1bb/cd137 agonist, in patients with advanced cancer
Segal, N. H., He, A. R., Doi, T., Levy, R., Bhatia, S., Pishvaian, M. J., Cesari, R., Chen, Y., Davis, C. B., Huang, B., et al. (2018) · Clinical Cancer Research
Cancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses
Cited by 267
- Verified
RPE65 Is an Iron(II)-dependent Isomerohydrolase in the Retinoid Visual Cycle
Moiseyev, G., Takahashi, Y., Chen, Y., Gentleman, S., Redmond, T. M., Crouch, R. K., & Ma, J.-X. (2006) · Journal of Biological Chemistry
Retinal Development and DisordersRetinoids in leukemia and cellular processes
Cited by 119
- Verified
Deoxycholic Acid Conjugates Are Muscarinic Cholinergic Receptor Antagonists
Raufman, J.-P., Chen, Y., Zimniak, P., & Cheng, K. (2002) · Pharmacology
Receptor Mechanisms and SignalingDrug Transport and Resistance Mechanisms
Cited by 47
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free